semaglutide en puerto rico leads U.S. growth in GLP-1 prescriptions in 2025 Control de Peso | IV

Counseling: Work with nutrition and mental health professionals to help address emotional issues related to eating and build new strategies to support nutritional and exercise goals

So does Mounjaro

Sweetman SC, ed

Tirzepatide tends to be the better fit when: the goal is more significant weight loss (15 percent or more of body weight), the patient has type 2 diabetes with A1C above target on prior therapies, prior single-pathway GLP-1 use produced limited results, or the patient tolerated GLP-1s reasonably well and wants a stronger next step

The more you have, the higher your resting metabolism and the better your long-term outcomes